Alerts will be sent to your verified email
Verify EmailGOLDLINE
|
Goldline Pharma.
|
Mono Pharmacare
|
Chandra Bhagat Pharm
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
18.23 % | 7.94 % | 3.03 % |
|
5yr average Equity Multiplier
|
2.92 | 3.7 | 2.92 |
|
5yr Average Asset Turnover Ratio
|
1.04 | 1.16 | 1.46 |
|
5yr Avg Net Profit Margin
|
6.35 % | 2.14 % | 0.71 % |
|
Price to Book
|
0.0 | 0.0 | 0.0 |
|
P/E
|
9.88 | 6.4 | 10.58 |
|
5yr Avg Cash Conversion Cycle
|
160.68 Days | 151.42 Days | 123.14 Days |
|
Inventory Days
|
97.06 Days | 219.92 Days | 97.15 Days |
|
Days Receivable
|
132.15 Days | 79.66 Days | 158.67 Days |
|
Days Payable
|
67.16 Days | 54.73 Days | 38.34 Days |
|
5yr Average Interest Coverage Ratio
|
2.27 | 2.12 | 1.63 |
|
5yr Avg ROCE
|
30.67 % | 11.4 % | 10.9 % |
|
5yr Avg Operating Profit Margin
|
16.99 % | 5.11 % | 1.16 % |
|
5 yr average Debt to Equity
|
1.44 | 2.07 | 0.76 |
|
5yr CAGR Net Profit
|
61.2 % | 34.58 % | 35.25 % |
|
5yr Average Return on Assets
|
6.66 % | 2.31 % | 1.04 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
57.29 % | 56.72 % | 73.02 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
57.29 % | 0.0 | 2.6 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Goldline Pharma.
|
Mono Pharmacare
|
Chandra Bhagat Pharm
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|
Location Wise Break-Up
|
|
Distribution Channel
|
Distribution Channel
|
-
|
-
|